Cargando…
Corrigendum to: Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trial
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462307/ https://www.ncbi.nlm.nih.gov/pubmed/30753500 http://dx.doi.org/10.1093/eurheartj/ehz029 |
Ejemplares similares
-
Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trial
por: Stone, Gregg W, et al.
Publicado: (2018) -
Corrigendum: Potent effects of dioscin against obesity in mice
por: Liu, Min, et al.
Publicado: (2015) -
The efficacy and safety of cangrelor in single vessel vs multivessel percutaneous coronary intervention: Insights from CHAMPION PHOENIX
por: Yong, Celina M., et al.
Publicado: (2019) -
Corrigendum: Abnormal proplatelet formation and emperipolesis in cultured human megakaryocytes from gray platelet syndrome patients
por: Di Buduo, Christian A., et al.
Publicado: (2016) -
CORRIGENDUM: A novel potent tumour promoter aberrantly overexpressed in most human cancers
por: Takahashi, Atsushi, et al.
Publicado: (2013)